Resul; Bahram

Patent Applications and Registrations

Patent applications and USPTO patent grants for Resul; Bahram.The latest application filed is for "composition and method for the treatment of psoriasis".

Company Profile

0.9.6

Resul; Bahram - Uppsala SE
Resul; Bahram - Upsala SE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Prostagladin derivatives for the treatment of glaucoma or ocular hypertension Grant 7,163,959 - Stjernschantz , et al. January 16, 2	2007-01-16
Composition and method for the treatment of psoriasis App 20060041016 - Stjernschantz; Johan ; et al.	2006-02-23
Prostagladin derivatives for the treatment of glaucoma or ocular hypertension App 20040167190 - Stjernschantz, Johan Wilhelm ; et al.	2004-08-26
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension App 20030181493 - Stjernschantz, Johan Wilhelm ; et al.	2003-09-25
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension App 20030166729 - Stjernschantz, Johan Wilhelm ; et al.	2003-09-04
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension App 20020173525 - Stjernschantz, Johan Wilhelm ; et al.	2002-11-21
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension App 20010014693 - Stjernschantz, Johan Wilhelm ; et al.	2001-08-16
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension Grant 6,030,999 - Stjernschantz , et al. February 29, 2	2000-02-29
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension Grant 5,849,791 - Stjernschantz , et al. December 15, 1	1998-12-15
Method and means for prevention of cataract Grant 5,773,472 - Stjernschantz , et al. June 30, 1	1998-06-30
Method and means for prevention and treatment of secondary cataract Grant 5,760,075 - Stjernschantz , et al. June 2, 1	1998-06-02
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension Grant 5,422,368 - Stjernschantz , et al. * June 6, 1	1995-06-06
Prostaglanddin derivatives for the treatment of glaucoma or ocular hypertension Grant 5,422,369 - Stjernschantz , et al. June 6, 1	1995-06-06
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension Grant 5,296,504 - Stjernschantz , et al. March 22, 1	1994-03-22
Method and composition for treatment of gastric and duodenal disorders Grant 5,223,537 - Stjernschantz , et al. June 29, 1	1993-06-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.